China Universal Asset Management Co., Ltd. Crinetics Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 19,664 shares of CRNX stock, worth $676,834. This represents 0.1% of its overall portfolio holdings.
Number of Shares
19,664
Previous 15,393
27.75%
Holding current value
$676,834
Previous $786,000
27.86%
% of portfolio
0.1%
Previous 0.09%
Shares
15 transactions
Others Institutions Holding CRNX
# of Institutions
255Shares Held
89.5MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$313 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.95MShares$239 Million0.07% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$214 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$211 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$186 Million0.03% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.85B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...